THC Biomed Intl Ltd  

(Public, CVE:THC)   Watch this stock  
Find more results for THC
- Close
CVE data delayed by 15 mins - Disclaimer
Currency in
Range     -
52 week 0.00 - 0.17
Open     -
Vol. 0.00
Mkt cap     -
P/E     -
Div/yield     -
EPS     -
Shares 84.54M
Beta     -
Inst. own     -


888 Dunsmuir St Suite 1100
+1-604-6086314 (Phone)
+1-604-6821666 (Fax)

Website links


THC BioMed Intl Ltd., formerly Thelon Capital Ltd., is a Canada-based development-stage company. The Company is engaged in the research and development, plant innovation and life sciences. It offers Seeds R Us services. It offers a range of consulting services, such as application review, standard operating procedures and acting liaison services, for licensed producer applicants. It also offers other services, such as quality assurance training, horticulture training, simulated inspections, physical security plans, and analytical services. Its subsidiaries include THC BioMed Ltd. and THC Meds Inc. THC BioMed Ltd. intends to cultivate medical marijuana, and conduct scientific research and development to offer products and services through two streams: medical marijuana sales to other Marihuana for Medical Purposes Regulations (MMPR) licensed producers, and products and services related to medical marijuana. THC Meds Inc. intends to distribute medical marijuana to the general public.

Officers and directors

Jason M. Walsh President, Chief Executive Officer, Director
Age: 44
Tracey St. Denis CPA Chief Financial Officer
Dianne M. Szigety Corporate Secretary
John Arthur Roozendaal Independent Director
Age: 45
Mark T. Tommasi Independent Director
Age: 40